Risk for vascular thromboembolic events (VaTEs) in patients (pts) with advanced urinary tract cancer (aUTC) treated with chemotherapy.

Authors

null

Aristotelis Bamias

Haematology- Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece

Aristotelis Bamias , George Tsironis , Ioannis Dimitriadis , Kimon Tzanis , Anna Tsiara , Aikaterini Xirokosta , Maria Kaparelou , Anastasios Kyriazoglou , Abis Cohen , Despoina Barbarousi , Konstantinos Koutsoukos , Michael Liontos , Roubini Zakopoulou , Euthymios Kostouros , Stamatina Pagoni , Charis Matsouka , Meletios A. Dimopoulos

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 383)

DOI

10.1200/JCO.2019.37.7_suppl.383

Abstract #

383

Poster Bd #

F18

Abstract Disclosures